Ireland· IE-PA-PA0281/124/001
Chlorpromazine Elixir BP 25 mg/5 ml Oral Solution
A chlorpromazine product containing chlorpromazine hydrochloride, registered in Ireland by Pinewood Laboratories Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Chlorpromazine is registered in 10 of 19 countries.
Countries holding a registration under ATC N05AA01 (chlorpromazine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Chlorpromazine · ATC N05AA01
10 / 19 countries
- Canada
- Finlandprice
- Franceprice
- Ireland
- Italyprice
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of chlorpromazine costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.61 in France to $2.57 in United States — a ×4.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Chlorpromazine · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- US United States$2.57 (acquisition cost)
- IT Italy$0.63
- FR France$0.61
The record
At a glance
HPRA (Ireland)- Active substance
- CHLORPROMAZINE HYDROCHLORIDE
- Manufacturer
- Pinewood Laboratories Ltd
- Country
- Ireland (IE)
- ATC code
- N05AA01
- ATC class
- Chlorpromazine
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0281/124/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
464 interactions on record for chlorpromazine.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Chlorpromazine · interactions on record
464 records
- 49 severe
- 301 moderate
- 10 minor
- 39 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
65 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Chlorpromazine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesChlorpromazineAlembic Pharmaceuticals Limited
- United KingdomChlorazin 100mg suppositoriesImported (Switzerland)
- NorwayChlorpromazineSandoz (2)
- FinlandKlorpromanOrion Corporation Orion Pharma
- FranceLARGACTIL 100 mg, comprimé pelliculé sécableNEURAXPHARM FRANCE
- SpainLARGACTIL 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULANeuraxpharm Spain S.L.U.
- CanadaTEVA-CHLORPROMAZINETEVA CANADA LIMITED
- ItalyLARGACTIL*20 cpr rivestite 100 mgTEOFARMA Srl
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Cyprus · Chlorpromazine Remedica
- Spain · Largactil
- France · Largactil
- United Kingdom (Northern Ireland) · Anaractil, Chlorpromazine
- Greece · Solidon, Zuledine
- Italy · Largactil
- Malta · Chlorpromazine Remedica
- Poland · Fenactil
- Portugal · Largactil, Largactil Im
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5cb02e2c-0887-479b-8cc3-016839d71dd1 GET /v1/drugs/5cb02e2c-0887-479b-8cc3-016839d71dd1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N05AA",
"N05AA01"
],
"strength": null,
"pa_number": "PA0281/124/001",
"substances": [
"CHLORPROMAZINE HYDROCHLORIDE"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "23/06/1983",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about chlorpromazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.